| Financial Year |
March 31 2023 |
| Monetary Funds |
213,911,120.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
265,092,121.08 |
| Advances to Suppliers |
9,283,856.20 |
| Other Receivables |
13,004,085.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
287,213,462.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
25,484.89 |
| Other Current Assets |
10,729,749.31 |
| Total Current Assets |
799,259,880.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
977,687.58 |
| Investment Properties |
46,247,811.01 |
| Fixed Assetes |
396,084,922.80 |
| Under-construction Projects |
72,749,462.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
90,431,658.81 |
| R&D expenses |
-- |
| Goodwill |
98,972,816.66 |
| Long-Term Deferred and Prepaid Expenses |
2,390,872.93 |
| Deferred Income Tax Assets |
21,718,157.17 |
| Other Non-Current Assets |
35,536,450.71 |
| Sub-Total of Non-Current Assets |
770,761,021.09 |
| Total Assets |
1,570,020,901.94 |
| Short-Term Loans |
107,008,931.82 |
| Trading Financial liabilities |
29,150.00 |
| Notes Payable |
-- |
| Accounts Payable |
398,601,462.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,095,225.47 |
| Taxes Payable |
5,229,629.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,587,888.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,026,163.25 |
| Other Current Liabilities |
1,000,106.50 |
| Sub-Total of Current Liabilities |
600,520,490.07 |
| Long-term Loans |
48,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
359,704.16 |
| Deferred Income Tax Liabilities |
5,824,359.76 |
| Other Non-Current Liabilities |
53,272,940.53 |
| Sub-Total of Non-Current Liabilities |
120,500,946.43 |
| Total Liabilities |
721,021,436.50 |
| Paid-In Capital(Or Share Stock) |
96,000,000.00 |
| Capital Surplus |
401,426,983.15 |
| Surplus Reserve |
28,218,395.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
273,522,892.45 |
| Minority Stockholder's Interest |
50,944,909.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
798,054,556.02 |
| Owner's Equity（Stockholder's Equity） |
848,999,465.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,570,020,901.94 |
